Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Published Online: 2015-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Aimery de Gramont•Annette K Larsen•Benoist Chibaudel•Benoit Samson•Christophe Louvet•Christophe Tournigand•Dewi Vernerey•Franck Bonnetain•Frédéric Viret•Gérard Lledo•Jean Latreille•Jean-François Ramée•Jérôme Dauba•May Mabro•Nathalie Aucoin•Nicole Tubiana-Mathieu•Olivier Dupuis•Paul Mésange•Thierry André•Werner Scheithauer•Yves Rinaldi
